You are here: Welcome » COVID-19 Vaccine Task Force

Menu

Rounding The Earth

Operation Uplift

Project List

This is an old revision of the document!

COVID-19 Vaccine Task Force

The COVID-19 Vaccine Task Force (VTF) was a Canadian public-private advisory board convened by the National Research Council of Canada (NRC) and Innovation, Science and Economic Development Canada (ISED).

History

Navdeep Bains, Minister of Innovation, Science and Industry, announced the membership of the COVID-19 Vaccine Task Force on August 5, 2020. Bains also announced the membership of the COVID-19 Therapeutics Task Force.1)

Participants

Members2)
Name Position Affiliation(s)
Joanne Langley Co-chair IWK Health Centre, Dalhousie University, Canadian Centre for Vaccinology, Canadian Immunization Research Network (CIRN), Chief Science Advisor of Canada's COVID-19 Expert Panel, Canadian Task Force on Preventative Health Care, National Advisory Committee on Immunization (NACI)
Mark Lievonen Co-chair JML Advisory Services, Sanofi Pasteur, BIOTECanada, Innovative Medicines Canada, Ontario Genomics, Markham Stoufville Hospital Foundation, Centre for the Advancement of Health Innovation, Ontario Institute for Cancer Research, Oncolytics Biotech, Acerus Pharmaceuticals, Quest PharmaTech, Public Policy Forum, York University, OncoQuest Pharmaceuticals, Biome Grow, Gairdner Foundation, Institute of Chartered Accountants of Ontario
Alan Bernstein Member Canadian Institute for Advanced Research (CIFAR), Global HIV Vaccine Enterprise, Canadian Institutes of Health Research (CIHR), Imperial Cancer Research Fund (ICRF), Ontario Cancer Institute, Samuel Lunenfeld Research Institute, Stand Up to Cancer Canada, Sabin-Aspen Vaccine Science & Policy Group, Bill & Melinda Gates Foundation
Robert Brunham Member University of British Columbia (UBC), UBCCDC Vaccine Research Laboratory, BC Centre for Disease Control and Prevention (BCCDC)
Michel de Wilde Member MDWConsultant, Sanofi Pasteur, Acambis, VaxDesign, GlaxoSmithKline
Bartha Knoppers Member Centre of Genomics and Policy (CGP), International Canger Genome Consortium, World Anti-Doping Agency (WADA), Global Alliance for Genomics and Health (GA4GH), Organisation for Economic Co-operation and Development (OECD), American Association for the Advancement of Science (AAAS), Hastings Center, Canadian Academy of Health Sciences (CAHS), Royal Society of Canada, International Commission on the Clinical Use of Human Germline Genome Editing
Gary Kobinger Member Infectious Diseases Research Centre (IDRC), National Microbiology Laboratory (NML), University of Manitoba, University of Pennsylvania, World Health Organization (WHO)
Christopher Procyshyn Member Vanrx Pharmasystems, QLT, International Society for Pharmaceutical Engineering (ISPE)
Benjamin Rovinski Member Lumira Ventures, Sanofi Pasteur, Antiva Biosciences, Antios Therapeutics, Aurinia Pharmaceuticals, Bright Angel Therapeutics, G1 Therapeutics, KAI Pharmaceuticals, Morphotek, Notch Therapeutics, Life Science Ontario, Ontario Genomics
1)
Jagric, A., Roy, C., Innovation, Science and Economic Development Canada, & Public Services and Procurement Canada. (2020, August 5). Government of Canada announces major steps in treating and preventing COVID-19 through vaccines and therapies. Government of Canada. http://archive.today/2022.12.16-235932/https://www.canada.ca/en/innovation-science-economic-development/news/2020/08/government-of-canada-announces-major-steps-in-treating-and-preventing-covid-19-through-vaccines-and-therapies.html
2)
National Research Council of Canada. (2020, August 5). COVID-19 Vaccine Task Force. Government of Canada. https://web.archive.org/web/20200808224638/https://nrc.canada.ca/en/corporate/covid-19-vaccine-task-force
Back to top